ID
16691
Beskrivning
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Screening Assessments
Länk
https://clinicaltrials.gov/ct2/show/NCT00373425
Nyckelord
Versioner (2)
- 2016-07-27 2016-07-27 -
- 2016-08-01 2016-08-01 -
Uppladdad den
1 augusti 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Screening Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Screening Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Beskrivning
Demographics
Beskrivning
Date of birth
Datatyp
date
Alias
- UMLS CUI [1]
- C0421451
Beskrivning
Gender
Datatyp
integer
Alias
- UMLS CUI [1]
- C0079399
Beskrivning
Ethnicity
Datatyp
integer
Alias
- UMLS CUI [1]
- C0015031
Beskrivning
Race
Datatyp
integer
Alias
- UMLS CUI [1]
- C0034510
Beskrivning
Race
Datatyp
text
Alias
- UMLS CUI [1]
- C0034510
Beskrivning
Screening Eligibility Criteria
Beskrivning
Inclusion Criteria
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1512693
Beskrivning
Inclusion Criteria
Datatyp
text
Alias
- UMLS CUI [1]
- C1512693
Beskrivning
Exclusion Criteria
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0680251
Beskrivning
Exclusion Criteria
Datatyp
text
Alias
- UMLS CUI [1]
- C0680251
Beskrivning
Eligibility Criteria
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C2348482
Beskrivning
Date screening consent was signed
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0021430
Beskrivning
IVRS Screening Number
Datatyp
text
Alias
- UMLS CUI [1]
- C1710477
Beskrivning
Treatment Eligibility Criteria
Beskrivning
Inclusion Criteria
Datatyp
boolean
Alias
- UMLS CUI [1]
- C1512693
Beskrivning
Inclusion Criteria
Datatyp
text
Alias
- UMLS CUI [1]
- C1512693
Beskrivning
Exclusion Criteria
Datatyp
boolean
Alias
- UMLS CUI [1]
- C0680251
Beskrivning
Exclusion Criteria
Datatyp
text
Alias
- UMLS CUI [1]
- C0680251
Beskrivning
Eligibility Criteria
Datatyp
integer
Alias
- UMLS CUI [1,1]
- C1516637
- UMLS CUI [1,2]
- C2348482
Beskrivning
Date main study consent was signed
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0021430
Beskrivning
IVRS Randomization
Similar models
Screening Assessments, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C0600091 (UMLS CUI [1,2])
C2348482 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C2348482 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,2])
Inga kommentarer